Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Yadira Lobaina"'
Autor:
Yadira Lobaina, Rong Chen, Edith Suzarte, Panchao Ai, Alexis Musacchio, Yaqin Lan, Glay Chinea, Changyuan Tan, Ricardo Silva, Gerardo Guillen, Ke Yang, Wen Li, Yasser Perera, Lisset Hermida
Publikováno v:
Vaccines, Vol 12, Iss 6, p 588 (2024)
A chimeric protein, formed by two fragments of the conserved nucleocapsid (N) and S2 proteins from SARS-CoV-2, was obtained as a recombinant construct in Escherichia coli. The N fragment belongs to the C-terminal domain whereas the S2 fragment spans
Externí odkaz:
https://doaj.org/article/431c941993434e4796debcbd54b112fb
Autor:
Yadira Lobaina, Rong Chen, Edith Suzarte, Panchao Ai, Vivian Huerta, Alexis Musacchio, Ricardo Silva, Changyuan Tan, Alejandro Martín, Laura Lazo, Gerardo Guillén-Nieto, Ke Yang, Yasser Perera, Lisset Hermida
Publikováno v:
Viruses, Vol 16, Iss 3, p 418 (2024)
Despite the rapid development of vaccines against COVID-19, they have important limitations, such as safety issues, the scope of their efficacy, and the induction of mucosal immunity. The present study proposes a potential component for a new generat
Externí odkaz:
https://doaj.org/article/01d7153718f0441e832abbe68eb14537
Autor:
Yadira Lobaina, Rong Chen, Panchao Ai, Liling Yang, Liz Alvarez-Lajonchere, Edith Suzarte, Changyuan Tan, Ricardo Silva, Zaixue Jiang, Ke Yang, Yasser Perera, Lisset Hermida
Publikováno v:
Viral Immunology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c29f34173a0cc53bd9d4ce3329d9f955
https://doi.org/10.1089/vim.2022.0186
https://doi.org/10.1089/vim.2022.0186
Autor:
Yadira Lobaina, Rong Chen, Edith Suzarte, Panchao Ai, Vivian Huerta, Changyuan Tan, Liz Alvarez-Lajonchere, Yang Liling, Alexis Musacchio, Ricardo Silva, Gerardo Enrique Guillén, Jiang Zaixue, Ke Yang, Yasser Perera, Lisset Hermida
Due to the rapid development of new variants of SARS-CoV-2 virus, as well as the real threat of new coronavirus zoonosis events, the development of a preventive vaccine with a broader scope of functionality is highly desirable. Previously, we reporte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a765d15dcd63a13da27d0a0cf2911341
https://doi.org/10.21203/rs.3.rs-2202663/v1
https://doi.org/10.21203/rs.3.rs-2202663/v1
Autor:
Yadira Lobaina, Rong Chen, Edith Suzarte, Panchao Ai, Vivian Huerta, Alexis Musacchio, Ricardo Silva, Changyuan Tan, Alejandro Martin, Laura Lazo, Gerardo Guillén, Ke Yang, Yasser Perera, Lisset Hermida
Despite the rapid development of vaccines and their reported efficacy for controlling the COVID-19 waves, two key challenges remain: the scope of the immunity against upcoming variants and zoonosis events, and the induction of mucosal immunity able t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::150037a3ec685b5553a4e7c5789f9f0d
https://doi.org/10.1101/2022.06.02.494502
https://doi.org/10.1101/2022.06.02.494502
Autor:
Yadira Lobaina, Jorge Aguiar, Eduardo Pentón, Gerardo Guillen, Mamun Al Mahtab, Helal Uddin, Ruksana Raihan, Fazle Akbar, Flor Pujol, Carmen L Loureiro, Julio Cesar Aguilar
Publikováno v:
Biotecnología Aplicada, Vol 32, Iss 3, Pp 3511-3513 (2015)
Externí odkaz:
https://doaj.org/article/317b287fff4e413fb6b9668a04196742
Autor:
Yadira Lobaina, Julio C Aguilar, Marie-Louise Michel, Maryline Bourgine, Gerardo Guillén, Sandrine Crabe
Publikováno v:
Antiviral Research. 153:23-32
Immunization routes and number of doses remain largely unexplored in therapeutic vaccination. The aim of the present work is to evaluate their impact on immune responses in naive and hepatitis B virus (HBV)-carrier mouse models following immunization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f322a9996c7c92d3027a8bd3b8838d6
https://doi.org/10.1016/j.antiviral.2018.02.019
https://doi.org/10.1016/j.antiviral.2018.02.019
Autor:
Marie-Louise Michel, Yadira Lobaina
Publikováno v:
Vaccine. 35:2308-2314
More than 250 million people worldwide are chronically infected with hepatitis B virus (CHB), and over half a million die each year due to CHB-associated liver complications such as cirrhosis and hepatocellular carcinoma. The translation of immunolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::942c65e09ed1f93e26550154c95b977f
https://doi.org/10.1016/j.vaccine.2017.03.049
https://doi.org/10.1016/j.vaccine.2017.03.049
Autor:
Yadira Lobaina Mato
Publikováno v:
International Journal of Pharmaceutics. 572:118813
Mucosal administration, and specifically nasal route, constitutes an alternative and promising strategy for drug and vaccine delivery. Mucosal routes have several advantages supporting their selective use for different pathologies. Currently, many ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c19fece72d1e5742296251daaaa445a
https://doi.org/10.1016/j.ijpharm.2019.118813
https://doi.org/10.1016/j.ijpharm.2019.118813
Autor:
Pablo Díaz, Julio C Aguilar, Arístides Aguilar, Jorge Aguiar, Eduardo Pentón, Guillermo Fernández, Nelvis Figueroa, Zurina Cinza, Yamila Leon, Verena Muzio, Gerardo G Nieto, Luis E Anillo, Freya Freyre, Ana Lidia Sánchez, Yadira Lobaina, Everardo Jerez
Publikováno v:
Euroasian Journal of Hepato-Gastroenterology
A novel therapeutic vaccine for chronic hepatitis B (CHB) treatment comprising the recombinant hepatitis B surface (HBsAg) and nucleocapsid (HBcAg) antigens has been developed. Preclinical and clinical trials (CT) evidenced safety and immunogenicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::742063da601f9fa327d2439941b1691a
https://pubmed.ncbi.nlm.nih.gov/30828555
https://pubmed.ncbi.nlm.nih.gov/30828555